-
Je něco špatně v tomto záznamu ?
Antioxidant defense system in familial hypercholesterolemia and the effects of lipoprotein apheresis
V. Blaha, M. Blaha, D. Solichová, LK. Krčmová, M. Lánská, E. Havel, P. Vyroubal, Z. Zadák, P. Žák, L. Sobotka,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
Grantová podpora
NV17-28882A
MZ0
CEP - Centrální evidence projektů
- MeSH
- alfa-tokoferol krev MeSH
- antioxidancia metabolismus MeSH
- biologické markery krev MeSH
- časové faktory MeSH
- chromatografie s reverzní fází MeSH
- dospělí MeSH
- erytrocytární membrána metabolismus MeSH
- hyperlipoproteinemie typ II krev diagnóza terapie MeSH
- látky reagující s kyselinou thiobarbiturovou metabolismus MeSH
- lidé středního věku MeSH
- lidé MeSH
- lipoproteiny krev MeSH
- oxidační stres * MeSH
- peroxidace lipidů MeSH
- senioři MeSH
- separace krevních složek metody MeSH
- studie případů a kontrol MeSH
- výsledek terapie MeSH
- vysokoúčinná kapalinová chromatografie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Oxidative stress is thought to play an important role in the pathogenesis of disorders associated with atherosclerosis. Alpha-tocopherol is considered to be an effective lipophilic antioxidant, which protects lipid membranes against peroxidation and thus prevents cell damage by reaction with free radicals. However, measurement of alpha-tocopherol concentration in serum does not reflect the content of α-tocopherol in membranes whereas erythrocyte alpha-tocopherol may be good indicator of antioxidative status. Therefore a simple isocratic reversed phase HPLC method has been developed and validated for the determination of alpha-tocopherol in human erythrocytes in a clinical setting. The content of alpha-tocopherol in human erythrocyte membrane and lipoperoxidation were studied in patients with severe hypercholesterolemia treated by lipoprotein apheresis. The group of hypercholesterolemic patients (n = 14) treated by lipoprotein apheresis was compared to healthy adult normolipidemic controls. After lipoprotein apheresis, the content of in membrane alpha-tocopherol did not change significantly despite decreased tocopherol in serum and lipoprotein fractions. We observed significantly decreased lipoperoxidation as revealed by serum TBARS, representing end products of lipid peroxidation, which increased from third day afterwards and remained significantly higher in comparison to controls until the next LDL-apheresis. We conclude that aggressive lipid lowering procedure with lipoprotein apheresis was associated with favorable transient decrease of lipoperoxidation. Simultaneously the cell membrane bound antioxidative defense mechanisms as reflected by the content of alpha-tocopherol in human erythrocyte membrane where not depressed in spite of its decreased plasma lipid carrier. Another variables involved remain to be investigated.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010284
- 003
- CZ-PrNML
- 005
- 20180420150718.0
- 007
- ta
- 008
- 180404s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.atherosclerosissup.2017.05.002 $2 doi
- 035 __
- $a (PubMed)29096832
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Blaha, V $u 3rd Department of Internal Medicine, Metabolism and Gerontology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic. Electronic address: blaha@lfhk.cuni.cz.
- 245 10
- $a Antioxidant defense system in familial hypercholesterolemia and the effects of lipoprotein apheresis / $c V. Blaha, M. Blaha, D. Solichová, LK. Krčmová, M. Lánská, E. Havel, P. Vyroubal, Z. Zadák, P. Žák, L. Sobotka,
- 520 9_
- $a Oxidative stress is thought to play an important role in the pathogenesis of disorders associated with atherosclerosis. Alpha-tocopherol is considered to be an effective lipophilic antioxidant, which protects lipid membranes against peroxidation and thus prevents cell damage by reaction with free radicals. However, measurement of alpha-tocopherol concentration in serum does not reflect the content of α-tocopherol in membranes whereas erythrocyte alpha-tocopherol may be good indicator of antioxidative status. Therefore a simple isocratic reversed phase HPLC method has been developed and validated for the determination of alpha-tocopherol in human erythrocytes in a clinical setting. The content of alpha-tocopherol in human erythrocyte membrane and lipoperoxidation were studied in patients with severe hypercholesterolemia treated by lipoprotein apheresis. The group of hypercholesterolemic patients (n = 14) treated by lipoprotein apheresis was compared to healthy adult normolipidemic controls. After lipoprotein apheresis, the content of in membrane alpha-tocopherol did not change significantly despite decreased tocopherol in serum and lipoprotein fractions. We observed significantly decreased lipoperoxidation as revealed by serum TBARS, representing end products of lipid peroxidation, which increased from third day afterwards and remained significantly higher in comparison to controls until the next LDL-apheresis. We conclude that aggressive lipid lowering procedure with lipoprotein apheresis was associated with favorable transient decrease of lipoperoxidation. Simultaneously the cell membrane bound antioxidative defense mechanisms as reflected by the content of alpha-tocopherol in human erythrocyte membrane where not depressed in spite of its decreased plasma lipid carrier. Another variables involved remain to be investigated.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antioxidancia $x metabolismus $7 D000975
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a separace krevních složek $x metody $7 D001781
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $7 D002851
- 650 _2
- $a chromatografie s reverzní fází $7 D056148
- 650 _2
- $a erytrocytární membrána $x metabolismus $7 D004910
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperlipoproteinemie typ II $x krev $x diagnóza $x terapie $7 D006938
- 650 _2
- $a peroxidace lipidů $7 D015227
- 650 _2
- $a lipoproteiny $x krev $7 D008074
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a oxidační stres $7 D018384
- 650 _2
- $a látky reagující s kyselinou thiobarbiturovou $x metabolismus $7 D017392
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a alfa-tokoferol $x krev $7 D024502
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Blaha, M $u 2nd Department of Internal Medicine, Hematology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic.
- 700 1_
- $a Solichová, D $u 3rd Department of Internal Medicine, Metabolism and Gerontology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic.
- 700 1_
- $a Krčmová, L Kujovská $u 3rd Department of Internal Medicine, Metabolism and Gerontology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic.
- 700 1_
- $a Lánská, M $u 2nd Department of Internal Medicine, Hematology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic.
- 700 1_
- $a Havel, E $u 3rd Department of Internal Medicine, Metabolism and Gerontology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic.
- 700 1_
- $a Vyroubal, P $u 3rd Department of Internal Medicine, Metabolism and Gerontology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic.
- 700 1_
- $a Zadák, Z $u 3rd Department of Internal Medicine, Metabolism and Gerontology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic.
- 700 1_
- $a Žák, P $u 2nd Department of Internal Medicine, Hematology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic.
- 700 1_
- $a Sobotka, L $u 3rd Department of Internal Medicine, Metabolism and Gerontology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic.
- 773 0_
- $w MED00006853 $t Atherosclerosis. Supplements $x 1878-5050 $g Roč. 30, č. - (2017), s. 159-165
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29096832 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180420150821 $b ABA008
- 999 __
- $a ok $b bmc $g 1287769 $s 1007096
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 30 $c - $d 159-165 $e 20170531 $i 1878-5050 $m Atherosclerosis supplements $n Atheroscler Suppl $x MED00006853
- GRA __
- $a NV17-28882A $p MZ0
- LZP __
- $a Pubmed-20180404
